InnovAge Holding Corp. (INNV)
USD 3.75
(-8.09%)
USD 3.75
(-8.09%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -23.18 Million USD | 53.07% |
| 2023 | -49.39 Million USD | -948.5% |
| 2022 | -4.71 Million USD | -27.22% |
| 2021 | -3.7 Million USD | -107.27% |
| 2020 | 50.93 Million USD | 28.38% |
| 2019 | 39.67 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -23.18 Million USD | 53.07% |
| 2024 Q2 | -1.78 Million USD | 83.35% |
| 2024 Q4 | -4.88 Million USD | -5.58% |
| 2024 Q1 | -10.71 Million USD | 2.05% |
| 2024 Q3 | -4.62 Million USD | -159.1% |
| 2023 Q3 | -8.16 Million USD | 40.29% |
| 2023 FY | -49.39 Million USD | -948.5% |
| 2023 Q4 | -10.94 Million USD | -33.95% |
| 2023 Q2 | -13.68 Million USD | 17.61% |
| 2023 Q1 | -16.6 Million USD | -34.47% |
| 2022 Q3 | -6.67 Million USD | -325.97% |
| 2022 Q4 | -12.34 Million USD | -85.03% |
| 2022 Q1 | 11.66 Million USD | 9.3% |
| 2022 Q2 | 2.95 Million USD | -74.67% |
| 2022 FY | -4.71 Million USD | -27.22% |
| 2021 Q4 | 10.66 Million USD | 298.81% |
| 2021 FY | -3.7 Million USD | -107.27% |
| 2021 Q2 | 20.54 Million USD | 153.8% |
| 2021 Q3 | -5.36 Million USD | -126.12% |
| 2021 Q1 | -38.17 Million USD | -289.29% |
| 2020 Q3 | 12.97 Million USD | 0.0% |
| 2020 Q4 | 20.17 Million USD | 55.46% |
| 2020 FY | 50.93 Million USD | 28.38% |
| 2019 FY | 39.67 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 104.576% |
| Addus HomeCare Corporation | 90.95 Million USD | 125.485% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | 344.437% |
| Amedisys, Inc. | 156.39 Million USD | 114.822% |
| American Oncology Network, Inc. | -49.15 Million USD | 52.842% |
| Astrana Health, Inc. | 84.61 Million USD | 127.395% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | 387.166% |
| IMAC Holdings, Inc. | -6.37 Million USD | -263.579% |
| biote Corp. | 28.65 Million USD | 180.888% |
| Cryo-Cell International, Inc. | -12.3 Million USD | -88.394% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 120.566% |
| COMPASS Pathways plc | -136.91 Million USD | 83.07% |
| DocGo Inc. | 15.05 Million USD | 253.969% |
| The Ensign Group, Inc. | 255.36 Million USD | 109.077% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 137.172% |
| Assure Holdings Corp. | -20.08 Million USD | -15.427% |
| The Joint Corp. | -2.07 Million USD | -1018.139% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 87.744% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | -47.608% |
| ModivCare Inc. | -139.94 Million USD | 83.436% |
| NewGenIvf Group Limited | 42.24 Thousand USD | 54974.296% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | -171.011% |
| Option Care Health, Inc. | 314.59 Million USD | 107.368% |
| P3 Health Partners Inc. | -167.86 Million USD | 86.191% |
| P3 Health Partners Inc. | -167.86 Million USD | 86.191% |
| The Pennant Group, Inc. | 25.16 Million USD | 192.097% |
| Surgery Partners, Inc. | 328 Million USD | 107.067% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | -702.743% |
| Talkspace, Inc. | -23.2 Million USD | 0.125% |
| Talkspace, Inc. | -23.2 Million USD | 0.125% |
| The Oncology Institute, Inc. | -77.01 Million USD | 69.903% |
| The Oncology Institute, Inc. | -77.01 Million USD | 69.903% |